Placeholder Banner

BIO Applauds Advancement of H.R. 3299

July 14, 2016

Washington, D.C. (July 14, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding yesterday’s passage by the House Energy and Commerce Committee of H.R. 3299, the Strengthening Public Health Emergency Response Act of 2016:

“BIO applauds yesterday’s broad, bipartisan vote by the House Energy & Commerce Committee to advance H.R. 3299, the Strengthening Public Health Emergency Response Act of 2016. If enacted, this bill would take substantial steps to address the many barriers which exist to developing medical countermeasures needed for protection against chemical, biological, radiological and nuclear (CBRN) threats as well as naturally-occurring infectious diseases such as Zika virus and pandemic influenza.

“The bill’s establishment of a Priority Review Voucher (PRV) program for material threat medical countermeasures is a particularly important provision which will help spur investment in the research and development of such products.

“We applaud Representatives Brooks and Eshoo, as well as Chairman Upton, for their leadership in advancing this vital legislation.”



About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.


Upcoming BIO Events 

BIO Animal Biotech Summit

September 21-23, 2016

Bethesda, MD

 

BIO IP & Diagnostics Symposium

September 29, 2016

Alexandria, VA

BIO Investor Forum

October 18-19, 2016

San Francisco, CA

 

BIO Latin America Conference

October 26-28, 2016
Grand Hyatt São Paulo, Brazil

 


###

Discover More
Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…
The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds. Announcing the new vision, mission and…